International Mito Patients (IMP): Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
Line 10: | Line 10: | ||
:::: Main responsibility: general management, project harmful drugs for mitoβs | :::: Main responsibility: general management, project harmful drugs for mitoβs | ||
:::: The Netherlands | :::: The Netherlands | ||
:::: Email: [[email protected] [email protected]] | :::: Email: [mailto:[email protected] [email protected]] | ||
Revision as of 10:59, 24 February 2017
- high-resolution terminology - matching measurements at high-resolution
International Mito Patients (IMP)
Description
The International Mito Patients is a network of national patient organizations involved in mitochondrial disease. Mitochondrial disease is a rare disease with a limited number of patients per country. The national patient organizations which are a member of IMP each are active and powerful in their own countries. By joining forces IMP can represent a large group of patients and as such be their voice on an international level.
Abbreviation: IMP
Reference: MitoPatients
Chair of IMP
- Elja van der Veer
- Main responsibility: general management, project harmful drugs for mitoβs
- The Netherlands
- Email: [email protected]
MitoPedia topics: MitoGlobal Organizations